Juha Matti Yrjänheikki

Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland.

Nostetta Oy (Nostetta) is a venture capital firm founded in 2013. The firm is headquartered in Kuopio, Finland.

Osuuskunta KPY operates as a long-term investor. It also rents office space and invests in securities. The company was founded in 1883 and is headquartered in Kuopio, Finland.

Pharmatest Services Oy offers translational research services for diseases with unmet clinical needs. It provides full-service research solutions for early drug development. Its focus is on preclinical efficacy models in the fields of cancer and skeletal diseases ranging from in vitro cell culture assays to in vivo models. In addition, the firm develops model and assay development services for its customers. The company was founded by Jussi Halleen and Pirkko Härkönen in 1998 and is headquartered in Turku, Finland.

Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki.

Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland.